AUA 2018 Prostate Cancer - Results from #49

Viewing 50-69 of 109 articles

AUA 2018: Phase II Clinical Trial in Prostate Cancer Evaluating 68Ga-PSMA-11 Detection on both Preoperative PET-CT and Immediate Postoperative Specimen Scanning

AUA 2018: Patient Reported Outcomes in SPARTAN, a Phase 3, Double-Blind, Randomized Study of Apalutamide plus ADT vs placebo plus ADT in Men with nmCRPC

AUA 2018: MRI Imaging - AUA Statement on its Use for Diagnosis, Staging, and Management

AUA 2018: Prostate Cancer: What PET to GET?

AUA 2018: Can Active Surveillance Really Reduce the Harms of PSA Testing? PRIAS-Study Implicates Caution

AUA 2018: Long-Term Outcomes of Active Surveillance for Prostate Cancer - Memorial Sloan Kettering Cancer Center Experience

AUA 2018: Effect of Selection and Referral Biases for the Treatment of Localized Prostate Cancer with Surgery or Radiation

AUA 2018: Can Free PSA Be Used as a Biomarker in Biochemical Recurrence after Surgery to Predict Castration Resistant Prostate Cancer?

AUA 2018: Active Surveillance of Prostate Cancer in African Americans during the MRI Era

AUA 2018: Risk of Men with Intermediate Risk Prostate Cancer Going On To Definitive Treatment During Active Surveillance: Does a High PSA Predict a Worse Outcome?

AUA 2018: Comparative Genomic Analysis of African American and Non-African American Prostate Cancers: A Report from the Decipher GRID Collaborative

AUA 2018: Impact of Transient ADT with Leuprorelin 11.25 Mg on the Histological Progression of Indolent Prostate Cancer–Results of a Phase III Trial vs Active Surveillance

AUA 2018: Analysis of Methylated DNA Markers for Prediction of Cancer Progression after Radical Prostatectomy

AUA 2018: Four-year Follow-up of a Phase-3 Prospective Randomized Trial of Vascular-Targeted Phototherapy Versus Active Surveillance for Low-Risk Prostate Cancer

AUA 2018: MRI-Guided Transurethral Ultrasound Ablation (TULSA) in Patients with Localized Prostate Cancer: Preliminary Results of TACT Pivotal Study

AUA 2018: Validation of the Decipher Biopsy Test to Predict Adverse Pathology in Men Diagnosed with Low and Favorable Intermediate Risk Prostate Cancer

AUA 2018: The Men’s Eating and Living (MEAL) Study: A Randomized Clinical Trial of a Diet Intervention in Men on Active Surveillance for Prostate Cancer

AUA 2018: Biomarker Debate: Adopt, Expand, Trust (PRO)

AUA 2018: Biomarker Debate: Adopt, Expand, Trust (CON)

AUA 2018: Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018

1
2
3
4
5
6

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.